Effect of probiotics on the immune function and clinical efficacy in children with recurrent respiratory tract infection

QU Hui; HE Jin′e; LI Jia; LI Yamei; WANG Kuanfeng

doi:10.7619/jcmp.201907021

Journal of Clinical Medicine in Practice > 2019 > 23(7): 80-83. > DOI: 10.7619/jcmp.201907021

QU Hui, HE Jin′e, LI Jia, LI Yamei, WANG Kuanfeng. Effect of probiotics on the immune function and clinical efficacy in children with recurrent respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 80-83. DOI: 10.7619/jcmp.201907021

Citation:

PDF (534 KB)

Effect of probiotics on the immune function and clinical efficacy in children with recurrent respiratory tract infection

Department of Pediatrics, Affiliated Hospital of Yan′an University, Yan′an, Shaanxi, 716000

More Information

Received Date: December 07, 2018
Accepted Date: January 17, 2019
Available Online: September 09, 2020
Published Date: April 14, 2019

Graphical Abstract

Abstract

Abstract

Objective To investigate the effect of probiotics on the immune function and clinical efficacy in children with recurrent respiratory tract infection (RRTI).
Methods A total of 92 RRTI children were continuously enrolled and were randomly divided into study group and control group, with 46 cases in each group. Both groups were given oral treatment of pidotimod, and the study group added Bifid Triple Viable Bifidobacterium Power, all the children were treated for 3 months, and followed-up time lasted for more than 1 year. The changes of serum C-reactive protein (CRP), procalcitonin(PCT), immunoglobulin G(IgG), pmmunoglobulin A(IgA) and T cell subgroups were compared between the two groups, and the clinical efficacy between the two groups were compared.
Results After treatment, serum CRP and PCT concentrations significantly decreased, serum IgG and IgA level significantly increased, the peripheral blood T cell count of CD4⁺ was significantly increased, CD8⁺ was significantly decreased in both groups when compared with that treatment before(P < 0.05). At the same time, the study group showed lower serum CRP and PCT concentration, higher serum IgG and IgA levels, higher peripheral blood CD4⁺ T cell count, and lower CD8⁺ T cell count after treatment, when compare to the control group(P < 0.05). However, there was no statistically difference between two groups in clinical efficiency (P>0.05).
Conclusion Probiotics can effectively improve the immune function and reduce the inflammation level in RRTI children.
- recurrent respiratory tract infection,
- immune function,
- inflammatory response,
- probiotics

FullText(HTML)

References (23)

References

[1]	Zhang X G, Ding F S, Li H N, et al. Low serum levels of vitamins A, D, and e are associated with recurrent respiratory tract infections in children living in northern China: a case control study[J]. PLoS One, 2016, 11(12): e0167689. doi: 10.1371/journal.pone.0167689
[2]	El-Azami-El-Idrissi M, Lakhdar-Idrissi M, Chaouki S, et al. Pediatric recurrent respiratory tract infections: when and how to explore the immune system(About 53 cases)[J]. Pan Afr Med J, 2016, 24: 53-60. http://europepmc.org/articles/PMC5012823/
[3]	Azizi G, Abolhassani H, Mahdaviani S A, et al. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study[J]. Pediatr Allergy Immunol, 2017, 28(5): 478-484. doi: 10.1111/pai.12735
[4]	Su G B, Chen X K, Liu Z Z, et al. Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children[J]. Cochrane Database Syst Rev, 2016, 12: CD011958. doi: 10.1002/14651858.CD011958/media/CDSR/CD011958/CD011958.pdf
[5]	Samuelson D R, Charles T P, de la Rua N M, et al. Analysis of the intestinal microbial community and inferred functional capacities during the host response to Pneumocystis pneumonia[J]. Exp Lung Res, 2016, 42(8/9/10): 425-439. doi: 10.1080/01902148.2016.1258442
[6]	Hauptmann M, Schaible U E. Linking microbiota and respiratory disease[J]. FEBS Lett, 2016, 590(21): 3721-3738. doi: 10.1002/1873-3468.12421
[7]	Caffarelli C, Cardinale F, Povesi-Dascola C, et al. Use of probiotics in pediatric infectious diseases[J]. Expert Rev Anti Infect Ther, 2015, 13(12): 1517-1535. doi: 10.1586/14787210.2015.1096775
[8]	Phelan P D. Recurrent respiratory tract infection[J]. Med J Aust, 1977, 1(10): 338-340. doi: 10.5694/j.1326-5377.1977.tb76720.x
[9]	Paśnik J. Vaccines nonspecific-immunostimulation in patients with recurrent respiratory infections[J]. Otolaryngol Pol, 2016, 70(6): 31-39. doi: 10.5604/01.3001.0009.4819
[10]	Schapowal A, Klein P, Johnston S L. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials[J]. Adv Ther, 2015, 32(3): 187-200. doi: 10.1007/s12325-015-0194-4
[11]	Saad K, Abo-Elela M G, El-Baseer K A, et al. Effects of bovine colostrum on recurrent respiratory tract infections and diarrhea in children[J]. Medicine (Baltimore), 2016, 95(37): e4560. doi: 10.1097/MD.0000000000004560
[12]	Dong F, Yu H, Ma J J, et al. Exploring association between gastrointestinal heat retention syndrome and recurrent respiratory tract infections in children: a prospective cohort study[J]. BMC Complement Altern Med, 2016, 16: 82-90. doi: 10.1186/s12906-016-1062-8
[13]	Smith-Norowitz T A, Bluth M H. Probiotics and diseases of altered IgE regulation: A short review[J]. J Immunotoxicol, 2016, 13(2): 136-140. doi: 10.3109/1547691X.2015.1044053
[14]	Singhi S C, Kumar S. Probiotics in critically ill children[J]. F1000Res, 2016, 5: 407-418. doi: 10.12688/f1000research.7630.1
[15]	Khailova L, Petrie B, Baird C H, et al. Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis[J]. PLoS One, 2014, 9(5): e97861. doi: 10.1371/journal.pone.0097861
[16]	Zeng J, Wang C T, Zhang F S, et al. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial[J]. Intensive Care Med, 2016, 42(6): 1018-1028. doi: 10.1007/s00134-016-4303-x
[17]	Johnstone J, Meade M, Marshall J, et al. Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: protocol for a feasibility randomized pilot trial[J]. Pilot Feasibility Stud, 2015, 1: 19-26. doi: 10.1186/s40814-015-0013-3
[18]	Bo L L, Li J B, Tao T Z, et al. Probiotics for preventing ventilator-associated pneumonia[J]. Cochrane Database Syst Rev, 2014(10): CD009066. http://www.ncbi.nlm.nih.gov/pubmed/25344083
[19]	Garaiova I, Muchová J, Nagyová Z, et al. Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study[J]. Eur J Clin Nutr, 2015, 69(3): 373-379. doi: 10.1038/ejcn.2014.174
[20]	季伟, 赵德育, 沈照波, 等. 酪酸杆菌588预防婴幼儿反复呼吸道感染多中心随机对照研究[J]. 儿科药学杂志, 2015, 21(4): 13-17.
[21]	Bertelsen R J, Jensen E T, Ringel-Kulka T. Use of probiotics and prebiotics in infant feeding[J]. Best Pract Res Clin Gastroenterol, 2016, 30(1): 39-48. doi: 10.1016/j.bpg.2016.01.001
[22]	Zajac A E, Adams A S, Turner J H. A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis[J]. Int Forum Allergy Rhinol, 2015, 5(6): 524-532. doi: 10.1002/alr.21492
[23]	Tian W J, Zhang T. Probiotics inhibit immune fluctuation in the intestinal mucous layer in rats[J]. Surg Today, 2015, 45(12): 1553-1559. doi: 10.1007/s00595-015-1123-5

Cited By

Get Citation

PDF

XML

Article views PDF downloads

Turn off MathJax

Article Contents

Abstract

References

Effect of probiotics on the immune function and clinical efficacy in children with recurrent respiratory tract infection

Abstract

References

Catalog

Export File

Citation

Format

Content